Chong Wang

Chong Wang received her Ph.D. in Immunology from Peking University, and received postdoc training at Harvard Medical School/Boston Children’s Hospital, supervised by Dr. Frederick Alt. She is currently a senior scientist at Analytical Development CMC, Cell Therapy Technology and Product Engine, Takeda. With her strong background and expertise in genomics, she has led the efforts in and made significant contributions to building the first next generation sequencing (NGS) based advanced analytical platform in Takeda Cell Therapy. Utilizing the NGS-based platforms, she has supported process development, safety assessment, IND filing, tech transfer, and other Cell Therapy CMC related activities. Now she is overseeing a team to expand, customize, and optimize NGS-based innovative advanced analytical toolbox to support more Cell Therapy programs.

Appearances

This speaker has made no appearances.